Will Rob Califf’s industry ties sink his FDA commissioner nomination?

December 1, 2021

Dr. Rob Califf’s extensive industry ties cast uncertainty on his nomination for FDA commissioner. The nominee’s financial disclosures, released this week reveal that his industry ties grew since leaving the position in 2016. In a report by Zachary Brennan, senior editor of Endpoints News, Califf must resign from at least 14 positions and cash out over $10 million worth of stock if confirmed. However, the previous confirmation of Dr. Scott Gottlieb, who also had substantial industry ties, raises doubts over whether these disclosures will affect his nomination prospects.

According to Brennan, “After more than a year of serving under an acting commissioner, the FDA is currently desperate for a Senate-confirmed leader who can provide a longer-term strategy and rebuild a workforce hit hard by the pandemic and political meddling from the last administration.”

Read the entire article by clicking here.